MOLOGEN Lifescience AG (FRA:U1DA)

Market Cap	3.86M +16.7%
Revenue (ttm)	45.12K
Net Income	-85.29K
EPS	n/a
Shares Out	1.38M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2
Open	2.800
Previous Close	2.800
Day's Range	2.800 - 2.800
52-Week Range	1.800 - 4.500
Beta	0.50
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About MOLOGEN Lifescience AG

MOLOGEN Lifescience AG operates as an investment company in Germany. It focuses on investments in seed and series A and B company phases, as well as in investment phases in the fields of fintech, blockchain, and related technologies. The company was formerly known as Finchain Capital Partners AG and changed its name to MOLOGEN Lifescience AG in April 2026. MOLOGEN Lifescience AG was founded in 2015 and is headquartered in Düsseldorf, Germany.

• Industry: Asset Management
• Sector: Financials
• Founded: 2015
• Employees: 1
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: U1DA

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 6, 2026

Data Sources Report a data error